250 related articles for article (PubMed ID: 10666256)
1. Relative sensitivity of hepatitis B virus and other hepatotropic viruses to the antiviral effects of cytokines.
McClary H; Koch R; Chisari FV; Guidotti LG
J Virol; 2000 Mar; 74(5):2255-64. PubMed ID: 10666256
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide inhibits hepatitis B virus replication in the livers of transgenic mice.
Guidotti LG; McClary H; Loudis JM; Chisari FV
J Exp Med; 2000 Apr; 191(7):1247-52. PubMed ID: 10748242
[TBL] [Abstract][Full Text] [Related]
3. Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver.
Guidotti LG; Borrow P; Hobbs MV; Matzke B; Gresser I; Oldstone MB; Chisari FV
Proc Natl Acad Sci U S A; 1996 May; 93(10):4589-94. PubMed ID: 8643448
[TBL] [Abstract][Full Text] [Related]
4. Interferon-regulated pathways that control hepatitis B virus replication in transgenic mice.
Guidotti LG; Morris A; Mendez H; Koch R; Silverman RH; Williams BR; Chisari FV
J Virol; 2002 Mar; 76(6):2617-21. PubMed ID: 11861827
[TBL] [Abstract][Full Text] [Related]
5. Different antiviral effects of IFNα and IFNβ in an HBV mouse model.
Zhou Y; Li S; Tang Z; Xu C; Huang S; Wu J; Dittmer U; Dickow J; Sutter K; Lu M; Yang D; Song J
Immunobiology; 2017 Mar; 222(3):562-570. PubMed ID: 27839836
[TBL] [Abstract][Full Text] [Related]
6. Persistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factors.
Chen SH; Wu HL; Kao JH; Hwang LH
PLoS One; 2012; 7(5):e36984. PubMed ID: 22615863
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-12 inhibits hepatitis B virus replication in transgenic mice.
Cavanaugh VJ; Guidotti LG; Chisari FV
J Virol; 1997 Apr; 71(4):3236-43. PubMed ID: 9060687
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of interferon-α to hepatitis B virus-infected cells using T-cell receptor-like antibodies.
Ji C; Sastry KS; Tiefenthaler G; Cano J; Tang T; Ho ZZ; Teoh D; Bohini S; Chen A; Sankuratri S; Macary PA; Kennedy P; Ma H; Ries S; Klumpp K; Kopetzki E; Bertoletti A
Hepatology; 2012 Dec; 56(6):2027-38. PubMed ID: 22684948
[TBL] [Abstract][Full Text] [Related]
9. Analysis of hepatitis B virus populations in an interferon-alpha-treated patient reveals predominant mutations in the C-gene and changing e-antigenicity.
Günther S; Paulij W; Meisel H; Will H
Virology; 1998 Apr; 244(1):146-60. PubMed ID: 9581787
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice.
Cavanaugh VJ; Guidotti LG; Chisari FV
J Virol; 1998 Apr; 72(4):2630-7. PubMed ID: 9525579
[TBL] [Abstract][Full Text] [Related]
11. The role of proinflammatory cytokines in wasting disease during lymphocytic choriomeningitis virus infection.
Kamperschroer C; Quinn DG
J Immunol; 2002 Jul; 169(1):340-9. PubMed ID: 12077263
[TBL] [Abstract][Full Text] [Related]
12. Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice.
Wieland SF; Guidotti LG; Chisari FV
J Virol; 2000 May; 74(9):4165-73. PubMed ID: 10756029
[TBL] [Abstract][Full Text] [Related]
13. Antiviral activity of various interferons and pro-inflammatory cytokines in non-transformed cultured hepatocytes infected with hepatitis B virus.
Isorce N; Testoni B; Locatelli M; Fresquet J; Rivoire M; Luangsay S; Zoulim F; Durantel D
Antiviral Res; 2016 Jun; 130():36-45. PubMed ID: 26971407
[TBL] [Abstract][Full Text] [Related]
14. Dissection of antiviral and immune regulatory functions of tumor necrosis factor receptors in a chronic lymphocytic choriomeningitis virus infection.
Suresh M; Gao X; Fischer C; Miller NE; Tewari K
J Virol; 2004 Apr; 78(8):3906-18. PubMed ID: 15047807
[TBL] [Abstract][Full Text] [Related]
15. Aplastic anemia rescued by exhaustion of cytokine-secreting CD8+ T cells in persistent infection with lymphocytic choriomeningitis virus.
Binder D; van den Broek MF; Kägi D; Bluethmann H; Fehr J; Hengartner H; Zinkernagel RM
J Exp Med; 1998 Jun; 187(11):1903-20. PubMed ID: 9607930
[TBL] [Abstract][Full Text] [Related]
16. Targeted deletion of FGL2 leads to increased early viral replication and enhanced adaptive immunity in a murine model of acute viral hepatitis caused by LCMV WE.
Khattar R; Luft O; Yavorska N; Shalev I; Phillips MJ; Adeyi O; Gao D; Bartczak A; Urbanellis P; Shyu W; Zhang J; Manuel J; Levy GA; Selzner N
PLoS One; 2013; 8(10):e72309. PubMed ID: 24146739
[TBL] [Abstract][Full Text] [Related]
17. A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control.
Namineni S; O'Connor T; Faure-Dupuy S; Johansen P; Riedl T; Liu K; Xu H; Singh I; Shinde P; Li F; Pandyra A; Sharma P; Ringelhan M; Muschaweckh A; Borst K; Blank P; Lampl S; Neuhaus K; Durantel D; Farhat R; Weber A; Lenggenhager D; Kündig TM; Staeheli P; Protzer U; Wohlleber D; Holzmann B; Binder M; Breuhahn K; Assmus LM; Nattermann J; Abdullah Z; Rolland M; Dejardin E; Lang PA; Lang KS; Karin M; Lucifora J; Kalinke U; Knolle PA; Heikenwalder M
J Hepatol; 2020 May; 72(5):960-975. PubMed ID: 31954207
[TBL] [Abstract][Full Text] [Related]
18. Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures.
Pasquetto V; Wieland SF; Uprichard SL; Tripodi M; Chisari FV
J Virol; 2002 Jun; 76(11):5646-53. PubMed ID: 11991993
[TBL] [Abstract][Full Text] [Related]
19. Noncytopathic clearance of lymphocytic choriomeningitis virus from the hepatocyte.
Guidotti LG; Borrow P; Brown A; McClary H; Koch R; Chisari FV
J Exp Med; 1999 May; 189(10):1555-64. PubMed ID: 10330434
[TBL] [Abstract][Full Text] [Related]
20. IFNα subtype-specific susceptibility of HBV in the course of chronic infection.
Xie X; Karakoese Z; Ablikim D; Ickler J; Schuhenn J; Zeng X; Feng X; Yang X; Dittmer U; Yang D; Sutter K; Liu J
Front Immunol; 2022; 13():1017753. PubMed ID: 36311794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
